|
GTCR has confirmed its buyout of Advent International's Czech generic drugmaker Zentiva, in a deal widely reported at €4.1bn.
The post Deal Roundup: GTCR confirms Zentiva buyout from Advent, Star Mountain exits DCCM appeared first on AltAssets Private Equity News.
|
|